Sotera Health Reports First-Quarter 2025 Results

Q1 2025 net revenues increased 2.6% to $255 million, compared to Q1 2024, or 4.4$13 million or $0.05 per diluted share, compared to net income of$6 million or $0.02 per diluted share in Q1 2024Q1 2025 Adjusted EBITDA(1) increased 8.8$122 million, compared to Q1 2024, or 11.2% on a constant currency basisQ1 2025 Adjusted EPS(1) of $0.14, an increase of$0.01 per diluted share, compared to Adjusted EPS of $0.13 in Q1 2024Company reaffirms full-year 2025 ...